OCWP
WST icon

Owl Creek Wealth Partners’s West Pharmaceutical WST Stock Holding History

Owl Creek Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Hold
81
– – 0.01% 528
2026
Q1 		$20.3K Buy
+81
New +$20.2K 0.01% 569

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Owl Creek Wealth Partners's WST Position: Q2 2026 in Review

Owl Creek Wealth Partners held its West Pharmaceutical (WST) position steady in Q2 2026 at 81 shares worth $29.1K. The position accounts for 0.01% of the portfolio, ranked #528.

Owl Creek Wealth Partners first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Owl Creek Wealth Partners held 81 shares of West Pharmaceutical worth $29.1K as of Q2 2026.
  • Owl Creek Wealth Partners left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #528 holding.
  • Owl Creek Wealth Partners first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.